daunorubicin has been researched along with Malaria, Falciparum in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clardy, J; Derbyshire, ER; Mota, MM; Prudêncio, M | 1 |
| Ahmad, M; Tabassum, F; Tarique, M; Tuteja, R | 1 |
| Chauhan, M; Tarique, M; Tuteja, R | 1 |
3 other study(ies) available for daunorubicin and Malaria, Falciparum
| Article | Year |
|---|---|
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Topics: Animals; Anopheles; Antimalarials; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Insect Vectors; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Male; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Treatment Outcome | 2012 |
Plasmodium falciparum UvrD activities are downregulated by DNA-interacting compounds and its dsRNA inhibits malaria parasite growth.
Topics: Antigens, Protozoan; Cells, Cultured; Daunorubicin; DNA Helicases; DNA, Protozoan; Ethidium; Etoposide; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Netropsin; Nogalamycin; Plasmodium falciparum; RNA, Double-Stranded; RNA, Protozoan | 2014 |
ATPase activity of Plasmodium falciparum MLH is inhibited by DNA-interacting ligands and dsRNAs of MLH along with UvrD curtail malaria parasite growth.
Topics: Adenosine Triphosphatases; Antimalarials; Daunorubicin; DNA Helicases; DNA Mismatch Repair; DNA, Protozoan; Drug Resistance; Ethidium; Etoposide; Malaria, Falciparum; Molecular Docking Simulation; MutL Protein Homolog 1; Netropsin; Nogalamycin; Plasmodium falciparum; RNA, Double-Stranded | 2017 |